NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2105948770|ref|WP_225354913|]
View 

diacylglycerol kinase family protein [Ligilactobacillus ruminis]

Protein Classification

diacylglycerol/lipid kinase family protein( domain architecture ID 11446635)

diacylglycerol/lipid kinase family protein may catalyze the ATP-dependent phosphorylation of diacylglycerol and/or other lipids, and is involved in the phospholipid biosynthetic process

CATH:  3.40.50.10330
EC:  2.7.1.-
SCOP:  3001940

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
LCB5 COG1597
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ...
1-301 2.04e-59

Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];


:

Pssm-ID: 441205 [Multi-domain]  Cd Length: 295  Bit Score: 192.37  E-value: 2.04e-59
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   1 MVKTFFIIVNNQASNGLKADVWQNIRTRLDSRKISYIFRKTKQVGNAKSLTKRYVshltKEEADetVVIVIGGDGTLTEV 80
Cdd:COG1597     1 AMMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAA----AEGAD--LVVAAGGDGTVNEV 74
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  81 LNGIKETPykhVPLAFIPIGENNGFAQGIGIASNPMTALEQILSAtEPVYYDIGEYTETthqshgYFFNDFGIGLDAFVI 160
Cdd:COG1597    75 ANGLAGTG---PPLGILPLGTGNDFARALGIPLDPEAALEALLTG-RTRRIDLGRVNGR------YFLNVAGIGFDAEVV 144
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 161 SlNTQAHKHKRLQKilnkfhlkfLAYIVSALEALINQESFSATIRI-GEKYEFfkHVAFVNVANHPYFDNGIVLSPTANV 239
Cdd:COG1597   145 E-RANRALKRRLGK---------LAYVLAALRALLRYRPFRLRIELdGEEIEG--EALLVAVGNGPYYGGGLRLAPDASL 212
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 2105948770 240 NDHKLDLLIADNLGFFKFIILAISIYFKKQLKLPYLHHYKSDQIHLIINSLEFGQIDGEEIG 301
Cdd:COG1597   213 DDGLLDVVVVRPLSRLRLLRLLPRLLRGRHLRHPGVRYFRAREVEIESDRPLPVQLDGEPLG 274
 
Name Accession Description Interval E-value
LCB5 COG1597
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ...
1-301 2.04e-59

Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];


Pssm-ID: 441205 [Multi-domain]  Cd Length: 295  Bit Score: 192.37  E-value: 2.04e-59
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   1 MVKTFFIIVNNQASNGLKADVWQNIRTRLDSRKISYIFRKTKQVGNAKSLTKRYVshltKEEADetVVIVIGGDGTLTEV 80
Cdd:COG1597     1 AMMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAA----AEGAD--LVVAAGGDGTVNEV 74
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  81 LNGIKETPykhVPLAFIPIGENNGFAQGIGIASNPMTALEQILSAtEPVYYDIGEYTETthqshgYFFNDFGIGLDAFVI 160
Cdd:COG1597    75 ANGLAGTG---PPLGILPLGTGNDFARALGIPLDPEAALEALLTG-RTRRIDLGRVNGR------YFLNVAGIGFDAEVV 144
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 161 SlNTQAHKHKRLQKilnkfhlkfLAYIVSALEALINQESFSATIRI-GEKYEFfkHVAFVNVANHPYFDNGIVLSPTANV 239
Cdd:COG1597   145 E-RANRALKRRLGK---------LAYVLAALRALLRYRPFRLRIELdGEEIEG--EALLVAVGNGPYYGGGLRLAPDASL 212
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 2105948770 240 NDHKLDLLIADNLGFFKFIILAISIYFKKQLKLPYLHHYKSDQIHLIINSLEFGQIDGEEIG 301
Cdd:COG1597   213 DDGLLDVVVVRPLSRLRLLRLLPRLLRGRHLRHPGVRYFRAREVEIESDRPLPVQLDGEPLG 274
TIGR00147 TIGR00147
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ...
1-307 3.99e-29

lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]


Pssm-ID: 161732 [Multi-domain]  Cd Length: 293  Bit Score: 113.37  E-value: 3.99e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   1 MVKTFFII-VNNQASNGLKadVWQNIRTRLDSRKISYIFRKTKQVGNAKsltkRYVSHLTKEEADetVVIVIGGDGTLTE 79
Cdd:TIGR00147   1 MAEAPAILnPTAGKSNDNK--PLREVIMLLREEGMEIHVRVTWEKGDAA----RYVEEARKFGVD--TVIAGGGDGTINE 72
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  80 VLNGIKetPYKHVP-LAFIPIGENNGFAQGIGIASNPMTALEQILsATEPVYYDIGEYTETTHqshgyFFNDFGIGldaF 158
Cdd:TIGR00147  73 VVNALI--QLDDIPaLGILPLGTANDFARSLGIPEDLDKAAKLVI-AGDARAIDMGQVNKQYC-----FINMAGGG---F 141
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 159 VISLNTQAHKhkRLqkilnKFHLKFLAYIVSALEALINQESFSATIRiGEKYEFFKHVAFVNVANHPYFDNGIVLSPTAN 238
Cdd:TIGR00147 142 GTEITTETPE--KL-----KAALGSLSYILSGLMRMDTLQPFRCEIR-GEGEHWQGEAVVFLVGNGRQAGGGQKLAPDAS 213
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2105948770 239 VNDHKLDLLIADNLGFFKFIILAISIYFKKQLKLPYLHHYKSDQIHLIINSLEFGQIDGEEIGNEYFDI 307
Cdd:TIGR00147 214 INDGLLDLRIFTNDNLLPALVLTLMSDEGKHTDNPNIIYGKASRIDIQTPHKITFNLDGEPLGGTPFHI 282
DAGK_cat pfam00781
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ...
5-135 4.76e-20

Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.


Pssm-ID: 425868 [Multi-domain]  Cd Length: 125  Bit Score: 84.17  E-value: 4.76e-20
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   5 FFIIVNNQASNGLKADVWQNIRTRLDSRKISYIFRKTKQVGNAKSLTKryvshltkeEADET---VVIVIGGDGTLTEVL 81
Cdd:pfam00781   2 LLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAR---------EAAEDgydRIVVAGGDGTVNEVL 72
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 2105948770  82 NGIKETPYKhVPLAFIPIGENNGFAQGIGIASNPMTALEQILSA-TEPVyyDIGE 135
Cdd:pfam00781  73 NGLAGLATR-PPLGIIPLGTGNDFARALGIPGDPEEALEAILKGqTRPV--DVGK 124
PRK13057 PRK13057
lipid kinase;
8-246 1.97e-14

lipid kinase;


Pssm-ID: 183857 [Multi-domain]  Cd Length: 287  Bit Score: 72.26  E-value: 1.97e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   8 IVNNQASNGLKAdvWQNIRTRLDSRKISYIFRKTKQVGNAKSLTKRYvshltKEEADetVVIVIGGDGTLTEVLNGIKET 87
Cdd:PRK13057    3 LVNRHARSGRAA--LAAARAALEAAGLELVEPPAEDPDDLSEVIEAY-----ADGVD--LVIVGGGDGTLNAAAPALVET 73
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  88 pykHVPLAFIPIGENNGFAQGIGIASNPMTALeQILSATEPVYYDIGEYtetthQSHgYFFNdfgigldafVISLNTQAH 167
Cdd:PRK13057   74 ---GLPLGILPLGTANDLARTLGIPLDLEAAA-RVIATGQVRRIDLGWV-----NGH-YFFN---------VASLGLSAE 134
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2105948770 168 KHKRLQKILnKFHLKFLAYIVSALEALINQESFSATIRIGEKYEFFKHVAfVNVANHPYFDNGIVLSPTANVNDHKLDL 246
Cdd:PRK13057  135 LARRLTKEL-KRRWGTLGYAIAALRVLRRSRPFTAEIEHDGRTERVKTLQ-VAVGNGRYYGGGMTVAHDATIDDGRLDL 211
DAGKc smart00046
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ...
6-115 5.75e-06

Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.


Pssm-ID: 214487 [Multi-domain]  Cd Length: 124  Bit Score: 44.98  E-value: 5.75e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770    6 FIIVNNQASNGLKADVWQNIRTRLdSRKISYIFRKTkqvGNAKSLtkryvsHLTKEEADETVVIVIGGDGTLTEVLNGIK 85
Cdd:smart00046   1 LVFVNPKSGGGKGEKLLRKFRLLL-NPRQVFDLTKK---GPAVAL------VIFRDVPDFNRVLVCGGDGTVGWVLNALD 70
                           90       100       110
                   ....*....|....*....|....*....|..
gi 2105948770   86 ETPYKH--VPLAFIPIGENNGFAQGIGIASNP 115
Cdd:smart00046  71 KRELPLpePPVAVLPLGTGNDLARSLGWGGGY 102
 
Name Accession Description Interval E-value
LCB5 COG1597
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ...
1-301 2.04e-59

Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];


Pssm-ID: 441205 [Multi-domain]  Cd Length: 295  Bit Score: 192.37  E-value: 2.04e-59
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   1 MVKTFFIIVNNQASNGLKADVWQNIRTRLDSRKISYIFRKTKQVGNAKSLTKRYVshltKEEADetVVIVIGGDGTLTEV 80
Cdd:COG1597     1 AMMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAA----AEGAD--LVVAAGGDGTVNEV 74
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  81 LNGIKETPykhVPLAFIPIGENNGFAQGIGIASNPMTALEQILSAtEPVYYDIGEYTETthqshgYFFNDFGIGLDAFVI 160
Cdd:COG1597    75 ANGLAGTG---PPLGILPLGTGNDFARALGIPLDPEAALEALLTG-RTRRIDLGRVNGR------YFLNVAGIGFDAEVV 144
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 161 SlNTQAHKHKRLQKilnkfhlkfLAYIVSALEALINQESFSATIRI-GEKYEFfkHVAFVNVANHPYFDNGIVLSPTANV 239
Cdd:COG1597   145 E-RANRALKRRLGK---------LAYVLAALRALLRYRPFRLRIELdGEEIEG--EALLVAVGNGPYYGGGLRLAPDASL 212
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 2105948770 240 NDHKLDLLIADNLGFFKFIILAISIYFKKQLKLPYLHHYKSDQIHLIINSLEFGQIDGEEIG 301
Cdd:COG1597   213 DDGLLDVVVVRPLSRLRLLRLLPRLLRGRHLRHPGVRYFRAREVEIESDRPLPVQLDGEPLG 274
TIGR00147 TIGR00147
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ...
1-307 3.99e-29

lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]


Pssm-ID: 161732 [Multi-domain]  Cd Length: 293  Bit Score: 113.37  E-value: 3.99e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   1 MVKTFFII-VNNQASNGLKadVWQNIRTRLDSRKISYIFRKTKQVGNAKsltkRYVSHLTKEEADetVVIVIGGDGTLTE 79
Cdd:TIGR00147   1 MAEAPAILnPTAGKSNDNK--PLREVIMLLREEGMEIHVRVTWEKGDAA----RYVEEARKFGVD--TVIAGGGDGTINE 72
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  80 VLNGIKetPYKHVP-LAFIPIGENNGFAQGIGIASNPMTALEQILsATEPVYYDIGEYTETTHqshgyFFNDFGIGldaF 158
Cdd:TIGR00147  73 VVNALI--QLDDIPaLGILPLGTANDFARSLGIPEDLDKAAKLVI-AGDARAIDMGQVNKQYC-----FINMAGGG---F 141
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 159 VISLNTQAHKhkRLqkilnKFHLKFLAYIVSALEALINQESFSATIRiGEKYEFFKHVAFVNVANHPYFDNGIVLSPTAN 238
Cdd:TIGR00147 142 GTEITTETPE--KL-----KAALGSLSYILSGLMRMDTLQPFRCEIR-GEGEHWQGEAVVFLVGNGRQAGGGQKLAPDAS 213
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2105948770 239 VNDHKLDLLIADNLGFFKFIILAISIYFKKQLKLPYLHHYKSDQIHLIINSLEFGQIDGEEIGNEYFDI 307
Cdd:TIGR00147 214 INDGLLDLRIFTNDNLLPALVLTLMSDEGKHTDNPNIIYGKASRIDIQTPHKITFNLDGEPLGGTPFHI 282
DAGK_cat pfam00781
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ...
5-135 4.76e-20

Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.


Pssm-ID: 425868 [Multi-domain]  Cd Length: 125  Bit Score: 84.17  E-value: 4.76e-20
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   5 FFIIVNNQASNGLKADVWQNIRTRLDSRKISYIFRKTKQVGNAKSLTKryvshltkeEADET---VVIVIGGDGTLTEVL 81
Cdd:pfam00781   2 LLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAR---------EAAEDgydRIVVAGGDGTVNEVL 72
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 2105948770  82 NGIKETPYKhVPLAFIPIGENNGFAQGIGIASNPMTALEQILSA-TEPVyyDIGE 135
Cdd:pfam00781  73 NGLAGLATR-PPLGIIPLGTGNDFARALGIPGDPEEALEAILKGqTRPV--DVGK 124
PRK13057 PRK13057
lipid kinase;
8-246 1.97e-14

lipid kinase;


Pssm-ID: 183857 [Multi-domain]  Cd Length: 287  Bit Score: 72.26  E-value: 1.97e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   8 IVNNQASNGLKAdvWQNIRTRLDSRKISYIFRKTKQVGNAKSLTKRYvshltKEEADetVVIVIGGDGTLTEVLNGIKET 87
Cdd:PRK13057    3 LVNRHARSGRAA--LAAARAALEAAGLELVEPPAEDPDDLSEVIEAY-----ADGVD--LVIVGGGDGTLNAAAPALVET 73
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  88 pykHVPLAFIPIGENNGFAQGIGIASNPMTALeQILSATEPVYYDIGEYtetthQSHgYFFNdfgigldafVISLNTQAH 167
Cdd:PRK13057   74 ---GLPLGILPLGTANDLARTLGIPLDLEAAA-RVIATGQVRRIDLGWV-----NGH-YFFN---------VASLGLSAE 134
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 2105948770 168 KHKRLQKILnKFHLKFLAYIVSALEALINQESFSATIRIGEKYEFFKHVAfVNVANHPYFDNGIVLSPTANVNDHKLDL 246
Cdd:PRK13057  135 LARRLTKEL-KRRWGTLGYAIAALRVLRRSRPFTAEIEHDGRTERVKTLQ-VAVGNGRYYGGGMTVAHDATIDDGRLDL 211
PRK13337 PRK13337
putative lipid kinase; Reviewed
41-298 1.98e-12

putative lipid kinase; Reviewed


Pssm-ID: 183982 [Multi-domain]  Cd Length: 304  Bit Score: 66.61  E-value: 1.98e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  41 TKQVGNAKSLTKRYVshltKEEADetVVIVIGGDGTLTEVLNGIKETPYKhvP-LAFIPIGENNGFAQGIGIASNPMTAL 119
Cdd:PRK13337   40 TTGPGDATLAAERAV----ERKFD--LVIAAGGDGTLNEVVNGIAEKENR--PkLGIIPVGTTNDFARALHVPRDIEKAA 111
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 120 EQILSA-TEPVyyDIGEYTETthqshgYFFNDFGIG----LDAFVISlntqahkhkRLQKILNKfhlkfLAYIVSALEAL 194
Cdd:PRK13337  112 DVIIEGhTVPV--DIGKANNR------YFINIAGGGrlteLTYEVPS---------KLKTMLGQ-----LAYYLKGIEML 169
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 195 inqESFSAT-IRI--------GEKYEFFkhVAFVN-VANhpyFDNgivLSPTANVNDHKLDLLIADNLGFFKFIILAISI 264
Cdd:PRK13337  170 ---PSLKATdVRIeydgklfqGEIMLFL--LGLTNsVGG---FEK---LAPDASLDDGYFDLIIVKKANLAELIHIATLA 238
                         250       260       270
                  ....*....|....*....|....*....|....*.
gi 2105948770 265 YFKKQLKLPYLHHYKSDQIhlIINSLEFGQI--DGE 298
Cdd:PRK13337  239 LRGEHIKHPKVIYTKANRI--KVSSFDKMQLnlDGE 272
PRK00861 PRK00861
putative lipid kinase; Reviewed
1-223 1.37e-10

putative lipid kinase; Reviewed


Pssm-ID: 234850 [Multi-domain]  Cd Length: 300  Bit Score: 61.18  E-value: 1.37e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   1 MVKTFFIIVNNQASNG-LKADVWQnIRTRLdSRKISYIFRKTKQVGNAKSLTKRYVSHLTKeeadetVVIVIGGDGTLTE 79
Cdd:PRK00861    1 MTRSACLIFNPVAGQGnPEVDLAL-IRAIL-EPEMDLDIYLTTPEIGADQLAQEAIERGAE------LIIASGGDGTLSA 72
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  80 VLNGIKETPykhVPLAFIPIGENNGFAQGIGIASNPMTALEQILsATEPVYYDIGeytetthqshgyFFNDF------GI 153
Cdd:PRK00861   73 VAGALIGTD---IPLGIIPRGTANAFAAALGIPDTIEEACRTIL-QGKTRRVDVA------------YCNGQpmillaGI 136
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 154 GLDAFVISLNTQAHKHkrlqkilnkfHLKFLAYIVSALEALINQESFSATIRIGEKYEFFKHVAfVNVAN 223
Cdd:PRK00861  137 GFEAETVEEADREAKN----------RFGILAYILSGLQQLRELESFEVEIETEDQIITTNAVA-VTVAN 195
PRK13059 PRK13059
putative lipid kinase; Reviewed
68-210 2.57e-10

putative lipid kinase; Reviewed


Pssm-ID: 183858  Cd Length: 295  Bit Score: 60.44  E-value: 2.57e-10
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  68 VIVIGGDGTLTEVLNGIKETPYKhVPLAFIPIGENNGFAQGIGIASNPMTALEQILSAtEPVYYDIGEYTETthqshgYF 147
Cdd:PRK13059   60 ILIAGGDGTVDNVVNAMKKLNID-LPIGILPVGTANDFAKFLGMPTDIGEACEQILKS-KPKKVDLGKINDK------YF 131
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 2105948770 148 FNDFGIGLdaFV-ISLNTQAHKHKRLQKilnkfhlkfLAYIVSALEALINQESFSATIRIGEKY 210
Cdd:PRK13059  132 INVASTGL--FTdVSQKTDVNLKNTIGK---------LAYYLKGLEELPNFRKLKVKVTSEEVN 184
PRK13055 PRK13055
putative lipid kinase; Reviewed
62-149 6.57e-09

putative lipid kinase; Reviewed


Pssm-ID: 237282 [Multi-domain]  Cd Length: 334  Bit Score: 56.54  E-value: 6.57e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  62 EADETVVIVIGGDGTLTEVLNGIkeTPYKHVP-LAFIPIGENNGFAQGIGIA-SNPMTALEQILSAtEPVYYDIGEYTET 139
Cdd:PRK13055   57 EAGFDLIIAAGGDGTINEVVNGI--APLEKRPkMAIIPAGTTNDYARALKIPrDNPVEAAKVILKN-QTIKMDIGRANED 133
                          90
                  ....*....|
gi 2105948770 140 ThqshgYFFN 149
Cdd:PRK13055  134 K-----YFIN 138
PRK13054 PRK13054
lipid kinase; Reviewed
52-248 4.35e-08

lipid kinase; Reviewed


Pssm-ID: 237281 [Multi-domain]  Cd Length: 300  Bit Score: 53.72  E-value: 4.35e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  52 KRYVshltkEEADE---TVVIVIGGDGTLTEVLNGIKETPYKHVP-LAFIPIGENNGFAQGIGIASNPMTALEQILSATe 127
Cdd:PRK13054   46 ARYV-----EEALAlgvATVIAGGGDGTINEVATALAQLEGDARPaLGILPLGTANDFATAAGIPLEPDKALKLAIEGR- 119
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 128 PVYYDIGEYTEtthqsHGYFFN----DFGigldafvislnTQ--AHKHKRLQKILNKfhlkfLAYIVSALEALINQESFS 201
Cdd:PRK13054  120 AQPIDLARVND-----RTYFINmatgGFG-----------TRvtTETPEKLKAALGG-----VAYLIHGLMRMDTLKPDR 178
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*...
gi 2105948770 202 ATIRiGEKYEfFKHVAFV-NVANHPYFDNGIVLSPTANVNDHKLDLLI 248
Cdd:PRK13054  179 CEIR-GPDFH-WQGDALViGIGNGRQAGGGQQLCPEALINDGLLDLRI 224
YegS_C pfam19279
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal ...
184-301 3.49e-06

YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal domain found in the YegS protein. It is related to the beta sandwich domain of NAD kinases. The structure of YegS reveals a two-domain protein with the active site crevice found between the two domains. The C-terminal domain contains 13 beta-strands and two alpha-helices. The likely substrate for YegS is phosphatidylglycerol.


Pssm-ID: 437111  Cd Length: 158  Bit Score: 46.42  E-value: 3.49e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 184 LAYIVSALEALINQESFSATIRI-GEKYEFfkHVAFVNVANHPYFDNGIVLSPTANVNDHKLDLLIADNLGFFKFIILAI 262
Cdd:pfam19279  25 LSYPAAALRALATFRPLRYRVTVdGEVREF--SAALVAVANSGYYGGGMRIAPDARVDDGLLDVVVIEAASRRTLLRLLP 102
                          90       100       110
                  ....*....|....*....|....*....|....*....
gi 2105948770 263 SIYFKKQLKLPYLHHYKSDQIHLIINSLEFGQIDGEEIG 301
Cdd:pfam19279 103 KVYDGRHVRLPQVEVLRGREVRIEADRPLPAGADGEVLG 141
DAGKc smart00046
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ...
6-115 5.75e-06

Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.


Pssm-ID: 214487 [Multi-domain]  Cd Length: 124  Bit Score: 44.98  E-value: 5.75e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770    6 FIIVNNQASNGLKADVWQNIRTRLdSRKISYIFRKTkqvGNAKSLtkryvsHLTKEEADETVVIVIGGDGTLTEVLNGIK 85
Cdd:smart00046   1 LVFVNPKSGGGKGEKLLRKFRLLL-NPRQVFDLTKK---GPAVAL------VIFRDVPDFNRVLVCGGDGTVGWVLNALD 70
                           90       100       110
                   ....*....|....*....|....*....|..
gi 2105948770   86 ETPYKH--VPLAFIPIGENNGFAQGIGIASNP 115
Cdd:smart00046  71 KRELPLpePPVAVLPLGTGNDLARSLGWGGGY 102
PRK12361 PRK12361
hypothetical protein; Provisional
6-299 9.53e-05

hypothetical protein; Provisional


Pssm-ID: 183473 [Multi-domain]  Cd Length: 547  Bit Score: 43.84  E-value: 9.53e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770   6 FIIVNNQASNGLKADVWQNIRTRLdSRKISYIFRKTKQVGNAKSLTKRYVshltKEEADetVVIVIGGDGTLTEVLNGIK 85
Cdd:PRK12361  246 WLIANPVSGGGKWQEYGEQIQREL-KAYFDLTVKLTTPEISAEALAKQAR----KAGAD--IVIACGGDGTVTEVASELV 318
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770  86 ETpykHVPLAFIPIGENNGFAQGI-GIASNPM---TALEQILSAtEPVYYDIGEytetthqshgyfFND------FGIGL 155
Cdd:PRK12361  319 NT---DITLGIIPLGTANALSHALfGLGSKLIpveQACDNIIQG-HTQRIDTAR------------CNDrlmlllVGIGF 382
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2105948770 156 DAFVISLNTQAHKHKRLQkilnkfhlkfLAYIVSALEALINQESFSATIRI-GEKYEFFKHVAFVnVAN-HPYFD----- 228
Cdd:PRK12361  383 EQKMIESADRERKNALGQ----------LAYLDGLWRAVNENETLTLTVTLdDAEPQTISTHSLV-VANaAPFTSllaqg 451
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 2105948770 229 NGivlSPtaNVNDHKLDLLIADNLGFFKFIILAIS------IYFKKQLKlpYLHHYKSDQIHLIINSLEFGQIDGEE 299
Cdd:PRK12361  452 GG---EP--NMTDGLLDITWLDSGGEPGEQLLSLAelalsgLGKEPEAN--KVHHAHAKKVTISSQKPIKYVIDGEL 521
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH